PZZ when you have a drug that is approved and it has a Patent it has exclusivity on that drug for the life of that Patent. The price obviously is higher than the market may dictate? Once the company goes to market PAR will price the treatment appropriately. Their is no other treatment as we speak at the moment. To quote a figure which you have is unrealistic. Patents are in place to ensure that the pharma company with the patent can ensure the research and development of the drug is priced to claw back the cost of going to the market
The Future, page-81
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 22.5¢ | $186.1K | 801.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 33599 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 65498 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |